Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyNanotechnology-based inhalation treatments for lung cancer: state of the artExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesBench-to-bedside translation of magnetic nanoparticlesNanotechnology in respiratory medicineNew surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studiesPhotothermal therapy of melanoma tumor using multiwalled carbon nanotubes.Encapsulation of catechin and epicatechin on BSA NPS improved their stability and antioxidant potential.Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.Nanoscale materials for hyperthermal theranostics.Cell death induced by AC magnetic fields and magnetic nanoparticles: current state and perspectives.PEGylated nanomedicines: recent progress and remaining concerns.Silica-based matrices: State of the art and new perspectives for therapeutic drug delivery.Lung cancer nanomedicine: potentials and pitfalls.Loco-regional administration of nanomedicines for the treatment of lung cancer.Cell Mechanosensors and the Possibilities of Using Magnetic Nanoparticles to Study Them and to Modify Cell Fate.Novel nanoparticulate systems for lung cancer therapy: an updated review.Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line.Magnetic nanoparticles in cancer diagnosis and treatment: a review.Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation.An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer.Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesFormulation design facilitates magnetic nanoparticle delivery to diseased cells and tissuesSynthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermiaDual-Drug Containing Core-Shell Nanoparticles for Lung Cancer TherapyComparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization.Advances in Magnetic Nanoparticles for Biomedical Applications.Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.Harmful at non-cytotoxic concentrations: SiO2-SPIONs affect surfactant metabolism and lamellar body biogenesis in A549 human alveolar epithelial cells.Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer.In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.Effects of superparamagnetic iron oxide nanoparticles on the longitudinal and transverse relaxation of hyperpolarized xenon gas.Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
P2860
Q26745710-CDE32623-007E-4301-8000-BC941E240753Q26774177-CA002BD2-B3AF-4FC1-80C1-D6BF53332775Q26828930-6C1A9653-372F-42CB-BBBF-7F5849C018C9Q26850547-7D5DD75F-E5BE-4870-9D92-4B6DE09EFBAAQ28395660-03A8D743-3D2F-49F9-8452-BF11483515D2Q28834078-A60E9514-2FF6-4D1A-8869-245E959CC2BEQ33834927-3D2507B4-9788-4F23-B002-1CEA951218C5Q35717132-861E4116-46B8-4865-B7B6-B0175C90F372Q35917427-76CC0A82-B055-49A9-92BF-6078859559E9Q36794937-FC6E0AC0-D579-4748-B326-20482E74A151Q38153091-5A22F1BC-9E66-49DD-8C02-A36D39C02D11Q38167826-AFFB9552-DCAB-471B-B3D0-871E0176031CQ38282549-1A1457D4-5BC5-45F8-A8D5-4C7F086293E0Q38608622-82173432-45DF-46A1-B604-04CE88D45DAEQ38639228-B6BDEE0C-BCE7-49E8-971B-91818043D08AQ38651707-40E05808-0130-496B-B18D-62252AAC3B4BQ38762917-D11EFBC3-1EA1-44AA-9479-1774F5C5565BQ38784185-F0EC0A71-0C3D-45A1-9DCB-41BD42EB361BQ38789238-69E972E8-A2F2-4F25-AD53-65F22D3F86FFQ38831669-51F6D798-B952-4093-A3C9-F8D6B5A9143BQ38915287-D93A6F5E-8273-489E-85CF-6A839DCB2725Q38925143-9CEE05BA-CC92-474E-A829-E95889E4D657Q39081912-ED5E392C-5D1A-4949-B1DC-ECE19A58F79FQ39306543-8C220085-9DA8-41CE-964E-F6EF6D0B239AQ41834840-273CCAB6-DA0C-48A7-A78A-EF106F06295BQ42083543-25AC61F5-2E16-4F91-9ABA-D230ED0FEA1EQ42379033-0A6CA203-CFD7-497E-8055-75B0927A9316Q43189563-5999D620-4CD5-4308-879D-A8FE0EBDD66CQ47216873-73ECE0A6-7AFF-4287-AA92-F815A48247C4Q48862997-56CAA9DD-63E5-4E2C-868A-058A76D97285Q50730700-36F42B50-A5D6-40DE-8D9E-AD5D1DE63705Q51059658-EFDB2218-AA72-41FF-9FD9-2AFA44515919Q51676931-1EFD01DA-EF69-40B8-B6CF-CEDB6567A338Q53400293-44921B85-5422-4B21-A582-6A4D2DD0C037Q54988869-FC30D749-AD7E-4681-A61C-4CBED53FB9F2Q59019514-CB500FB8-CDD6-4496-AC1C-FBDF488213E1
P2860
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@ast
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@en
type
label
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@ast
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@en
prefLabel
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@ast
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@en
P2093
P2860
P1433
P1476
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
@en
P2093
Jayanth Panyam
Tanmoy Sadhukha
Timothy S Wiedmann
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.03.061
P577
2013-04-13T00:00:00Z